Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

TXMD US Equity

TherapeuticsMD, Inc.Health Care · Pharmaceutical Preparations · CIK 25743 · FY ends Dec 31
$2.03
+0.02 (+1.00%)
USD · as of 2026-08-19 · marketstack
1 8-K filing · 0 13D · 1 13G
DateEventWhat happened / filerSource
2026-08-118-K 7.01Regulation FD disclosuresec.gov ↗
2026-08-118-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-08-0513G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Baselake Partners, LPsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-08-05

Every row is a filed document, checked against its EDGAR index.